N. N. Blokhin Russian Cancer Research Center, Kashirskoye sh. 24, Moscow, 115478 Russia.
Clin Epigenetics. 2010 Dec;1(3-4):85-100. doi: 10.1007/s13148-010-0010-6. Epub 2010 Sep 14.
There exist two paradigms about the nature of cancer. According to the generally accepted one, cancer is a by-product of design limitations of a multi-cellular organism (Greaves, Nat Rev Cancer 7:213-221, 2007). The essence of the second resides in the question "Does cancer kill the individual and save the species?" (Sommer, Hum Mutat 3:166-169, 1994). Recent data on genetic and epigenetic mechanisms of cell transformation summarized in this review support the latter point of view, namely that carcinogenesis is an evolutionary conserved phenomenon-a programmed death of an organism. It is assumed that cancer possesses an important function of altruistic nature: as a mediator of negative selection, it serves to preserve integrity of species gene pool and to mediate its evolutionary adjustment. Cancer fulfills its task due apparently to specific killer function, understanding mechanism of which may suggest new therapeutic strategy.
关于癌症的本质存在两种范式。根据普遍接受的观点,癌症是多细胞生物设计局限性的副产品(Greaves,Nat Rev Cancer 7:213-221,2007)。第二种范式的本质在于“癌症是否会杀死个体而拯救物种?”(Sommer,Hum Mutat 3:166-169,1994)。本文综述了细胞转化的遗传和表观遗传机制的最新数据,支持后一种观点,即致癌作用是一种进化保守的现象——生物体的程序性死亡。人们认为,癌症具有重要的利他功能:作为负选择的中介,它有助于保持物种基因库的完整性,并介导其进化调整。癌症显然是由于其特有的杀伤功能而完成其任务的,了解其机制可能会提出新的治疗策略。